Vir Biotechnology, Inc. VIR
9.15 USD -0.10 (-1.08%)
Regular-session close
9.30 +0.15 +1.64%
After hours · Nov 18, 6:26 PM ET
9.02 Day range 9.36
5.32 52-week range 14.38
- YTD
- +51.74%
- 1 year
- +66.36%
VIR revenue history
Revenue is income from the company’s ordinary business activities.
68,556,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 68,556,000 | -5,649,000 | -7.61% |
| FY 2024 | 2024-12-31 | 74,205,000 | -11,975,000 | -13.90% |
| FY 2023 | 2023-12-31 | 86,180,000 | -1,529,617,000 | -94.67% |
| FY 2022 | 2022-12-31 | 1,615,797,000 | 520,382,000 | 47.51% |
| FY 2021 | 2021-12-31 | 1,095,415,000 | 1,019,047,000 | 1334.39% |
| FY 2020 | 2020-12-31 | 76,368,000 | 68,277,000 | 843.86% |
| FY 2019 | 2019-12-31 | 8,091,000 | -2,577,000 | -24.16% |
| FY 2018 | 2018-12-31 | 10,668,000 | 7,960,000 | 293.94% |
| FY 2017 | 2017-12-31 | 2,708,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:00:49.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
